In this episode, we dive into the GLP-1 conversation that’s everywhere—between “miracle drug” hype, scary side-effect stories, and the stigma that comes with seeking help. We share the kind of patient scenario we’re seeing constantly, talk about why these meds went viral, and explore what often gets lost in online discourse: nuance, individualized risk/benefit decisions, and real informed consent. We also tease what we consider when someone has health anxiety, a history of disordered eating, or is getting information (or prescriptions) through less-regulated channels. 

00:00 Podcast intro and mission
01:18 Patient story GLP-1 dilemma
03:23 Social media claims and stigma
06:29 Why GLP-1s went viral
12:06 Nugget of truth and nuance
13:51 What GLP-1 drugs are
17:57 Benefits beyond diabetes
23:57 Fatty liver and metabolism
28:37 Is weight loss a benefit
34:22 Weight Stigma in Care
35:53 When to Discuss Weight
37:46 Is Weight Loss a Benefit
39:05 BMI vs Metabolic Health
40:21 GLP-1 Weight Loss Data
43:31 Long-Term Outcomes Matter
44:53 Weight Cycling Risks
47:58 Other Potential Benefits
48:51 Common Side Effects
49:59 Muscle and Bone Loss
52:44 Cancer and Eye Concerns
56:13 Mental Health Signals
59:21 Telehealth Misuse Risks
01:02:45 Cost and Sustainability
01:05:23 Alternatives Like Metformin
01:06:29 Long-Term Treatment Reality
01:09:37 Undereating Risks
01:10:04 Early Intervention Debate
01:11:12 Biology Over Willpower
01:11:58 Environment Versus Meds
01:13:58 Weight Cycling Reality
01:15:31 Compounded GLP-1 Dangers
01:21:05 Informed Consent Lessons
01:22:42 Stigma and Patient Fears
01:27:08 Food Noise Explained
01:31:40 Fatphobia and Epigenetics
01:35:05 How We Counsel Patients
01:43:01 Resources and Disclaimer

📖 Read the full episode summary, sources, and resources on our Substack:
 👉www.theantisocialdoctors.com